TELA Bio, Inc. (TELA) Financials

TELA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 87.3 million 56.8 million
2023-06-30 94.4 million 54.4 million
2023-03-31 58.8 million 55.6 million
2022-12-31 67.9 million 53.6 million

TELA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.1 million 1.4 million
2023-06-30 -11.4 million 1.3 million
2023-03-31 -11.7 million 1.1 million
2022-12-31 -12.0 million 1.0 million

TELA Net Income

No data available :(

TELA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 58.2 million - 345000
2023-06-30 65.3 million 40.2 million 343000
2023-03-31 30.1 million 40.1 million 342000
2022-12-31 42.0 million 39.9 million 340000

TELA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 24.5 million
2023-06-30 23.2 million
2023-03-31 19.2 million
2022-12-31 19.2 million

TELA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 134000 2.4 million 3.7 million 14.5 million
2023-06-30 157000 2.5 million 3.5 million 14.6 million
2023-03-31 115000 2.1 million 3.6 million 13.5 million
2022-12-31 1.0 million 2.7 million 3.2 million 11.6 million

TELA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 15.1 million 4.7 million
2023-06-30 14.5 million 4.3 million
2023-03-31 11.9 million 4.0 million
2022-12-31 11.6 million 3.4 million

TELA

Price: $4.72

52 week price:
4.24
11.61

Earnings Per Share: -2.04 USD

P/E Ratio: -3.52

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Volume: 32300

Market Capitalization: 131.1 million

Links: